Drawing for CST BIOSCIENCES

USPTO serial 86119908

CST BIOSCIENCES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SMITH, BRIDGETT G
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CST BIOSCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven A. Abreu

STEVEN A. ABREU SUNSTEIN KANN MURPHY & TIMBERS LLP125 SUMMER STBOSTON, MA 02110-1618UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Antibodies, enzymes and nucleic acids for scientific and research use; Antibodies for the detection of signaling molecules, post-translational modifications on signaling molecules, non-radioactive kinase and other enzyme assays, kinase and other enzyme inhibitors designed for use in biotechnological and biomedical research; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic kits consisting of reagents for scientific or research use; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; reagents for use in the development of therapeutic substances; reagents for research purposes; reagents for use in scientific apparatus for chemical and biological analysisACTIVE—
005Diagnostic kits consisting of reagents for therapeutic use; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic reagents and contrast media for medical use; diagnostic reagents for therapeutic use; diagnostic reagents for medicinal use; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; medical diagnostic reagentsACTIVE—
042Biological research in the field of proteomics and cellular signal transduction; consulting services in the fields of biotechnology, pharmaceutical research and developments, laboratory testing, diagnostics and pharmacogenetics; custom design and development of chemical reagents and biochemical assays for others; diagnostic services in the field of proteomics and cellular signal transduction; providing reagent sample testing and diagnostic services for others in the fields of science and scientific researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 18, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 18, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 21, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 17, 2017EX3GSOU EXTENSION 3 GRANTED—
Feb 17, 2017EXT3SOU EXTENSION 3 FILED—
Feb 17, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 13, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 12, 2016EX2GSOU EXTENSION 2 GRANTED—
Sep 9, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 18, 2016EXT2SOU EXTENSION 2 FILED—
Aug 18, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 27, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 25, 2016EX1GSOU EXTENSION 1 GRANTED—
Jan 25, 2016EXT1SOU EXTENSION 1 FILED—
Jan 25, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 18, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 23, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 23, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 16, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 13, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 7, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 7, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 1, 2015ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 1, 2014GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 1, 2014GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 1, 2014CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 5, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 5, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 5, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 5, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 5, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 5, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2014ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 1, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 11, 2014ALIEASSIGNED TO LIE—
Mar 11, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Mar 10, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 10, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 10, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 3, 2014DOCKASSIGNED TO EXAMINER—
Dec 3, 2013MPMKNOTICE OF PSEUDO MARK E-MAILED—
Nov 30, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 19, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance